A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, randomized, double-blind, vehicle-controlled, SAD / MAD study evaluating
three dose levels of PBI-100 topical cream in healthy adult volunteers and/or subjects with
psoriasis.